Amy Zhou is the Founder & CEO of Revefore, a health and longevity-focused company headquartered in Australia. With over a decade of experience across health products, biotechnology, and cross-border operations, she is recognised for building businesses with strong regulatory foundations and long-term scalability.

Under Amy’s leadership, Revefore is structured on Australia’s TGA pharmaceutical-grade regulatory framework, creating a high-barrier operating model that integrates compliant manufacturing, product standardisation, and global market readiness. Her strategic focus is on building repeatable, regulation-resilient health solutions capable of sustaining growth across cycles.

Amy is committed to disciplined governance, capital efficiency, and long-term value creation for institutional and strategic investors.